A first of its kind study by Cancer Research UK reveals premature cancer death rates in 35–69-year-olds fell by more than a third over 25 years Improvements in the UK are a result of smokefree policies, prevention measures, early detection programmes like cancer screening, and more effective treatment options...
research News
TEL AVIV, Israel – Gaucher disease (GD), a rare autosomal recessive disorder, is characterized by the deficiency of the lysosomal enzyme β-glucocerebrosidase, leading to the accumulation of glucosylceramide in macrophages throughout the body. Accordingly, the primary disease features are hepatosplenomegaly, hypersplenism, anemia, thrombocytopenia, and bone involvement. There are three types...
Turku, Finland – Researchers at the University of Turku, have uncovered how the new bexmarilimab therapy alters the function of immune cells so that they can infiltrate the tumor in cancer patients who do not respond to any other current therapies. Cancer immunotherapy utilizes the body’s own defense machinery, the...
Kyoto, Japan — An old campaign slogan for cough syrup, “It tastes awful. And it works,” seemed to imply that any sweet content might have diminished the medicinal effect. Sweetness, in the case of cancer, appears as a chain of sugar molecules attached to proteins by beta1,4-galactosyltransferase-3, or B4GALT3 According...
Lehi, Utah — CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that will use the body’s immune system to fight cancer, reported that CEO Ryan Davies discussed the future of the cancer therapeutic industry with Dr. Looper, a life-long researcher in the chemistry field. Ryan Looper, Ph.D., Colorado State...
Santa Barbara, Calif. — CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune system to fight cancer, today announced that its UCLA research team has created a promising new drug candidate for treating recurrent Ewing sarcoma, a deadly children’s cancer. Ewing sarcoma is a rare...
Strasbourg, France – A new study presented at the European Psychiatric Association Congress 2024 reveals a significant association between prenatal cannabis use disorder (CUD) and an increased risk of neurodevelopmental disorders in offspring, including attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and intellectual disability (ID). Cannabis remains by...
LUND, Sweden – Cantargia (STO:CANTA) (Cantargia AB; Nasdaq Stockholm:CANTA) today reported new data highlighting the potential of the CAN10 antibody, currently in phase I clinical development, as therapy in systemic sclerosis. All signaling systems targeted by CAN10 (IL-1, IL-33 and IL-36) were found to be highly upregulated in patient skin...
San Francisco, California – Grant of up to $11 million will fund a clinical trial at UCSF that uses a smarter new CAR-T guided by precision technology. A type of gene therapy called CAR-T that has extended survival for thousands of patients with leukemia and other blood cancers is being...
Basel, Switzerland – Chimeric antigen receptor (CAR) T-cell therapy represents one of the most significant advancements in modern immunotherapy. Originally developed to treat hematologic malignancies, this approach involves genetically modifying a patient’s T cells to express an artificial receptor capable of recognizing specific tumor antigens. Upon re-infusion, these tailored T...